NCT00554814

Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency

Interest of Biofer ® Compound Used in Blédilait Follow on Milk and Growing Milk on Iron Status Evolution in Infant With Latent Iron Deficiency

• Status: Suspended
• Phase: N/A
• Study type: Interventional
• Enrollment: 249 (estimated)
• Sponsor: Bledina · Industry
• Sex: All
• Age: 6 Months – 12 Months
• Healthy volunteers: Not accepted

Summary

The primary purpose of the study is to demonstrate the superiority of Bledilait milk (Biofer® 2mg/100kcal) in comparison with ferrous sulphate supplemented milk (2 mg/100 kcal) in infants (6 to 12 months) with latent iron deficiency by measuring serum ferritin value after 2 months of consumption of studied milks.

Conditions

• Latent Iron Deficiency

Interventions

Type	Name	Description
DRUG	Bledilait Biofer®	Bledilait Biofer® 2 mg/100 kcal
DRUG	Milk supplemented with ferrous sulphate	Milk supplemented with ferrous sulphate (2mg/100kcal)
DRUG	Blédilait Biofer®	Blédilait Biofer® milk (1,1mg/100kcal)

Timeline

• Start date: 2007-11-01
• Primary completion: 2008-11-01
• Completion: 2008-12-01
• First posted: 2007-11-07
• Last updated: 2008-11-17

Locations

1 site across 1 country: France